(Q34188405)

31 July 2017

1 reference

title

Recent advances in inflammatory bowel disease. (English)

1 reference

inflammatory bowel diseases

31 July 2017

0 references

author name string

Farrell RJ

series ordinal

1

1 reference

PubMed ID

11256517

31 July 2017

Banerjee S

series ordinal

2

1 reference

PubMed ID

11256517

31 July 2017

Peppercorn MA

series ordinal

3

1 reference

31 July 2017

1 February 2001

1 reference

Critical Reviews in Clinical Laboratory Sciences

31 July 2017

1 reference

31 July 2017

38

1 reference

31 July 2017

1

1 reference

31 July 2017

33-108

1 reference

Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.

31 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Composition of human colonic mucin. Selective alteration in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Ion exchange chromatography of purified colonic mucus glycoproteins in inflammatory bowel disease: absence of a selective subclass defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Effects of smoking on the urine excretion of oral 51Cr EDTA in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

The influence of zinc status and malnutrition on immunological function in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Leucocyte endothelial cell adhesion in indomethacin induced intestinal inflammation is correlated with faecal pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Childhood infections and the risk of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Stress and infectious disease in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Stress and immunity in humans: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Smoking, the oral contraceptive pill, and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Familial occurrence of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Preliminary evidence for genetic anticipation in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Familial occurrence of complement dysfunction in Crohn's disease: correlation with intestinal symptoms and hypercatabolism of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Genetic markers may predict disease behavior in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Mapping of a susceptibility locus for Crohn's disease on chromosome 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Fecal Hydrogen Sulfide Production in Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Role of the faecal stream in the maintenance of Crohn's colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Enteric Microflora in IBD: Pathogens or Commensals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Absence of measles-virus genome in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Crohn's disease and the mycobacterioses: a review and comparison of two disease entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Mycobacterium paratuberculosis DNA not detected in Crohn's disease tissue by fluorescent polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Controlled trial of antituberculous chemotherapy in Crohn's disease: a five year follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

High Fas ligand expression on lymphocytes in lesions of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

The jejunal secretion of histamine is increased in active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Review article: platelets in inflammatory bowel disease--pathogenetic role and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Differential expression of interleukin 1 receptor antagonist isoforms in human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Apoptosis of human intestinal epithelial cells after bacterial invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Proinflammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Topical treatment of ulcerative proctitis with lidocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Prostaglandins and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

The colonic epithelium in ulcerative colitis: an energy-deficiency disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Antibodies to interleukin 12 abrogate established experimental colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Characterization of spontaneous colitis in cotton-top tamarins (Saguinus oedipus) and its response to sulfasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Oxidants and free radicals in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Effects of mesalamine on the hsp72 stress response in rat IEC-18 intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Modulation by cytokines of glucocorticoid action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Frequency of glucocorticoid resistance and dependency in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Oral budesonide as maintenance therapy in Crohn's disease--results of a 12-month study. Global Budesonide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Double blind, placebo controlled trial of metronidazole in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Molecular and cellular effects of methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

The relationship between infliximab treatment and lymphoma in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Interleukin-10 gene knock-out mice: a model of chronic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Transdermal nicotine for active ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Nicotine enemas for active ulcerative colitis--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Ketotifen therapy for acute ulcerative colitis in children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Inflammatory bowel disease--a radical view

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Childhood Exposure to Environmental Tobacco Smoke and the Risk of Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Stimulation of transforming growth factor β1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20014091084173

21 January 2018

Identifiers

DOI

10.1080/20014091084173

1 reference

31 July 2017

1 reference

PubMed ID

11256517